• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Lexicon Pharmaceutcl (NQ: LXRX )

    1.620 +0.010 (+0.62%)
    Streaming Delayed Price Updated: 4:00 PM EDT, May 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,069,736
    Open 1.630
    Bid (Size) 1.620 (1)
    Ask (Size) 1.630 (9)
    Prev. Close 1.610
    Today's Range 1.590 - 1.640
    52wk Range 0.9200 - 3.730
    Shares Outstanding 144,474,452
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Cytokinetics Reveals More From The Study That Boosted Shares 83% In A Day
    The company is hoping to take on Bristol Myers Squibb's Camzyos, a treatment for obstructive HCM. 
    Via Investor's Business Daily
    LXRX Stock Earnings: Lexicon Pharmaceuticals Meets EPS, Misses Revenue for Q1 2024
    LXRX stock results show that Lexicon Pharmaceuticals met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    +1.89%
    +1.89%
    1 Month
    +1.25%
    +1.25%
    3 Month
    -36.22%
    -36.22%
    6 Month
    +43.36%
    +43.36%
    1 Year
    -36.96%
    -36.96%

    More News

    Read More
    Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Lexicon Pharmaceuticals: Q4 Earnings Insights
    Via Benzinga
    Lexicon Pharmaceuticals's Earnings: A Preview
    Via Benzinga
    Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    ACADIA Pharmaceuticals, Ocular Therapeutix, Asana And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
    Via Benzinga
    Dow Turns Higher; GDS Holdings Shares Climb
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Exposures Product Safety
    Crude Oil Edges Higher; Lexicon Pharmaceuticals Shares Jump
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Top 4 Health Care Stocks You May Want To Dump In February
    Via Benzinga
    Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    3 Under-the-Radar Stocks With 340% to 762% Upside in 2024, According to Select Wall Street Analysts
    Via The Motley Fool
    3 of the Fastest-Growing Stocks on the Planet in 2024
    Via The Motley Fool
    7 Magnificent Stocks That Can Double Your Money in 2024
    Via The Motley Fool
    3 Growth Stocks Expected to Skyrocket in 2024, According to Wall Street
    Via The Motley Fool
    Insiders Buying Blend Labs And 3 Other Stocks Under $2
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Plus Therapeutics Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    AMD, Yum China, Paycom Software And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Via Benzinga
    Global Diabetes Care Market Size Expected To Reach $41.71 Billion By 2027
    Via FinancialNewsMedia
    Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Lexicon Pharmaceuticals And 3 Other Stocks Under $2 Insiders Are Buying
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Startek Shares Are Trading Higher By 29%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Why Shares of Lexicon Pharmaceuticals Are Up Tuesday
    Via The Motley Fool
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.